CN104710437A - 一种双苄生物素脱苄制d-生物素的改进方法 - Google Patents
一种双苄生物素脱苄制d-生物素的改进方法 Download PDFInfo
- Publication number
- CN104710437A CN104710437A CN201510158140.6A CN201510158140A CN104710437A CN 104710437 A CN104710437 A CN 104710437A CN 201510158140 A CN201510158140 A CN 201510158140A CN 104710437 A CN104710437 A CN 104710437A
- Authority
- CN
- China
- Prior art keywords
- biotin
- benzyl
- solution
- formula
- hydrogen bromide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title claims abstract description 144
- 238000000034 method Methods 0.000 title claims abstract description 48
- 229940068840 d-biotin Drugs 0.000 title abstract 5
- 229960002685 biotin Drugs 0.000 title abstract 4
- 235000020958 biotin Nutrition 0.000 title abstract 4
- 239000011616 biotin Substances 0.000 title abstract 4
- 238000006264 debenzylation reaction Methods 0.000 title abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims abstract description 91
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000012074 organic phase Substances 0.000 claims abstract description 27
- 239000003849 aromatic solvent Substances 0.000 claims abstract description 24
- 238000001914 filtration Methods 0.000 claims abstract description 20
- 229940005605 valeric acid Drugs 0.000 claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- 239000013078 crystal Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003513 alkali Substances 0.000 claims abstract description 12
- 238000003756 stirring Methods 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 11
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 11
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 10
- 238000010992 reflux Methods 0.000 claims abstract description 7
- 239000011665 D-biotin Substances 0.000 claims description 66
- 235000000638 D-biotin Nutrition 0.000 claims description 66
- 229930003756 Vitamin B7 Natural products 0.000 claims description 53
- 235000011912 vitamin B7 Nutrition 0.000 claims description 53
- 239000011735 vitamin B7 Substances 0.000 claims description 53
- -1 benzyl D-biotin Chemical compound 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 47
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 44
- 239000000758 substrate Substances 0.000 claims description 43
- PGESDSQUYHPLRY-FUDKSRODSA-N 5-[(3as,4s,6ar)-1,3-dibenzyl-2-oxo-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1([C@H]2[C@@H](N(C1=O)CC=1C=CC=CC=1)CS[C@H]2CCCCC(=O)O)CC1=CC=CC=C1 PGESDSQUYHPLRY-FUDKSRODSA-N 0.000 claims description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- 238000002425 crystallisation Methods 0.000 claims description 25
- 230000008025 crystallization Effects 0.000 claims description 24
- 239000008346 aqueous phase Substances 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- 239000010413 mother solution Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 238000001953 recrystallisation Methods 0.000 claims description 9
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 9
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 8
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical group ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 claims description 4
- 238000000638 solvent extraction Methods 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 3
- 238000013517 stratification Methods 0.000 claims description 3
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 3
- 239000000047 product Substances 0.000 abstract description 25
- 230000008901 benefit Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 4
- 238000001514 detection method Methods 0.000 abstract description 2
- 239000012071 phase Substances 0.000 abstract 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000004809 thin layer chromatography Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 20
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 18
- 239000012535 impurity Substances 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 235000011121 sodium hydroxide Nutrition 0.000 description 11
- 238000004821 distillation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 125000006278 bromobenzyl group Chemical group 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 0 CN([C@@]1[C@](*2)[C@](CCCCC(O)=O)SC1)C2=O Chemical compound CN([C@@]1[C@](*2)[C@](CCCCC(O)=O)SC1)C2=O 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 description 1
- SMDXWVJAZUVKHF-ZOBUZTSGSA-N C[N](Cc1ccccc1)([C@@H](CS[C@H]1CCCCC(O)=O)[C@@H]1N1)C1=O Chemical compound C[N](Cc1ccccc1)([C@@H](CS[C@H]1CCCCC(O)=O)[C@@H]1N1)C1=O SMDXWVJAZUVKHF-ZOBUZTSGSA-N 0.000 description 1
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical class [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510158140.6A CN104710437B (zh) | 2015-04-04 | 2015-04-04 | 一种双苄生物素脱苄制d‑生物素的改进方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510158140.6A CN104710437B (zh) | 2015-04-04 | 2015-04-04 | 一种双苄生物素脱苄制d‑生物素的改进方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104710437A true CN104710437A (zh) | 2015-06-17 |
CN104710437B CN104710437B (zh) | 2017-01-25 |
Family
ID=53410217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510158140.6A Active CN104710437B (zh) | 2015-04-04 | 2015-04-04 | 一种双苄生物素脱苄制d‑生物素的改进方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104710437B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109928970A (zh) * | 2017-12-19 | 2019-06-25 | 新发药业有限公司 | 一种瑞利巴坦中间体的简便制备方法 |
CN112457327A (zh) * | 2020-10-27 | 2021-03-09 | 安徽泰格维生素实业有限公司 | 一种d-生物素的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374312A (zh) * | 2002-03-27 | 2002-10-16 | 复旦大学 | d-生物素的合成方法 |
WO2004041830A2 (en) * | 2002-11-07 | 2004-05-21 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of biotin |
CN103788112A (zh) * | 2012-11-02 | 2014-05-14 | 菏泽市方明制药有限公司 | 一种苄基生物素脱苄制备生物素的方法 |
-
2015
- 2015-04-04 CN CN201510158140.6A patent/CN104710437B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1374312A (zh) * | 2002-03-27 | 2002-10-16 | 复旦大学 | d-生物素的合成方法 |
WO2004041830A2 (en) * | 2002-11-07 | 2004-05-21 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of biotin |
CN103788112A (zh) * | 2012-11-02 | 2014-05-14 | 菏泽市方明制药有限公司 | 一种苄基生物素脱苄制备生物素的方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109928970A (zh) * | 2017-12-19 | 2019-06-25 | 新发药业有限公司 | 一种瑞利巴坦中间体的简便制备方法 |
CN109928970B (zh) * | 2017-12-19 | 2020-04-28 | 新发药业有限公司 | 一种瑞利巴坦中间体的简便制备方法 |
CN112457327A (zh) * | 2020-10-27 | 2021-03-09 | 安徽泰格维生素实业有限公司 | 一种d-生物素的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104710437B (zh) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106588758B (zh) | 一种2-肼基吡啶衍生物的合成工艺 | |
WO2008134936A1 (fr) | Procédé d'extraction de thréonine à partir de liqueur de fermentation de thréonine | |
CN102241606A (zh) | 一种n-氰乙基苯胺的清洁生产方法 | |
CN109553645B (zh) | 一种提取发酵溶液中低含量红霉素a的方法 | |
CN109134287B (zh) | 一种甜菜碱或甜菜碱盐酸盐生产中副产氯化钠的提纯方法 | |
CN104710437A (zh) | 一种双苄生物素脱苄制d-生物素的改进方法 | |
CN107522614B (zh) | 一种低碳卤代烷烃用于分离与提纯混合二元酸中戊二酸的方法 | |
CN106397236A (zh) | 一种甘氨酸的提纯方法 | |
CN103724288B (zh) | 原甲酸三乙酯法制备1h-四氮唑乙酸的后处理方法 | |
CN102399205A (zh) | 一种霉酚酸纯化工艺 | |
CN110590587A (zh) | 一种3-氯-l-丙氨酸甲酯盐酸盐的合成方法 | |
CN106883227B (zh) | 通过麦角菌发酵废料制备麦角新碱的方法 | |
CN104355990B (zh) | 一种d-乙酯生产中回收和套用l-(+)-酒石酸的方法 | |
JP2008043327A (ja) | コハク酸の製造方法 | |
CN113563215B (zh) | 一种甘氨酸的生产工艺 | |
CN102452962A (zh) | 一种2-丙烯酰胺基-2-甲基丙磺酸的合成方法 | |
CN110872274B (zh) | 分步析晶提纯高残渣盐酸氨丙啉的方法 | |
CN114933588A (zh) | 雷贝拉唑钠粗品的精制方法 | |
CN101195594B (zh) | 一种从生产吐氏酸的废水中提取有效成分的制备方法 | |
CN109836424B (zh) | 一种环保型茶碱钠盐甲基化制备咖啡因的方法 | |
CN108863862B (zh) | 用偏三甲苯混合溶剂对粗品双酚s精制的方法 | |
CN112778112A (zh) | 一种维生素k3的合成方法及装置 | |
CN105440053B (zh) | 一种gcle结晶母液的回收方法 | |
CN114671789B (zh) | 一种硝磺草酮连续结晶的方法 | |
CN104326901B (zh) | D-乙酯生产中回收和套用l-(+)-酒石酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311401 Dongzhou industrial function zone, Fuyang District, Zhejiang, Hangzhou Patentee after: HANGZHOU KEXING BIOCHEM. CO., LTD. Address before: 311401 Dongzhou industrial function zone, Fuyang District, Zhejiang, Hangzhou Patentee before: Fuyang Kexing Biochemical Co., Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Improved method for preparing d-biotin from bisbenzyl biotin by debenzylation Effective date of registration: 20200520 Granted publication date: 20170125 Pledgee: North Bank Financial Leasing Co., Ltd Pledgor: HANGZHOU KEXING BIOCHEM Co.,Ltd. Registration number: Y2020330000255 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220209 Granted publication date: 20170125 Pledgee: North Bank Financial Leasing Co.,Ltd. Pledgor: HANGZHOU KEXING BIOCHEM Co.,Ltd. Registration number: Y2020330000255 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An improved method for debenzylation of dibenzyl biotin to d-biotin Effective date of registration: 20220429 Granted publication date: 20170125 Pledgee: Fuyang Zhejiang rural commercial bank Limited by Share Ltd. the Fuchun River branch Pledgor: HANGZHOU KEXING BIOCHEM Co.,Ltd. Registration number: Y2022330000630 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |